Placebo on day 0, 28

BIOLOGICAL2 trials

Sponsors

Chinese Academy of Medical Sciences, Institute of Medical Biology, Chinese Academy of Medical Sciences

Conditions

DiarrheaRotavirus InfectionRotavirus Infections

Phase 1

Safety and Preliminary Immunogenicity Study of Inactivated Vaccine for Prevention of Rotavirus Infection

Chinese Academy of Medical SciencesRotavirus Infection

Start: 2020-12-03End: 2021-08-31Updated: 2020-12-10

Phase 2

Phase II Clinical Trial of the Inactivated Rotavirus Vaccine

RecruitingNCT06080906

Institute of Medical Biology, Chinese Academy of Medical SciencesDiarrhea, Rotavirus Infections

Start: 2023-10-20End: 2025-06-17Target: 600Updated: 2024-01-03

Related Papers

A randomized, double-blind, placebo-controlled phase I clinical trial of rotavirus inactivated vaccine (Vero cell) in a healthy adult population aged 18–49 years to assess safety and preliminary observation of immunogenicity

Vaccine2024-05-242 citations